Zacks Investment Research on MSN
GSK stock declines 9% in a month: Time to buy, hold or exit?
GSK GSK shares have lost 8.8% in a month, mainly because investors were disappointed with the company maintaining guidance ...
Zacks Investment Research on MSN
Here's why GSK (GSK) is a strong value stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...
GSK GSK stock has risen 18.6% in the past three months. The price recovery was backed by strong third-quarter results, wherein the British drugmaker beat estimates for both earnings and sales. The ...
GSK disclosed that non-executive director Dr. Hal Barron acquired American Depositary Shares of the company through the reinvestment of dividends in his GSK 401(k) plan account. The transaction, ...
GSK plc (NYSE:GSK) is one of the 7 Most Profitable Value Stocks to Buy Right Now. GSK plc (NYSE:GSK) is one of the most profitable value stocks to buy right now. On March 13, GSK plc announced that ...
CAMP4 Therapeutics Corporation (NASDAQ: CAMP) on Thursday entered into a strategic research, collaboration, and license agreement with GSK Plc (NYSE: GSK). The collaboration aims to identify and ...
As the U.S. emerges from its longest-ever government shutdown, tariffs continue to drag on the economy, inflation rates are heating up, and the Federal Reserve has resumed cutting interest rates to ...
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results